- Home
- EGP vs ITCI Comparison
EGP vs ITCI Comparison
Compare EGP & ITCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EGP
- ITCI
- Stock Information
- Founded
- EGP 1969
- ITCI 2002
- Country
- EGP United States
- ITCI United States
- Employees
- EGP N/A
- ITCI N/A
- Industry
- EGP Real Estate Investment Trusts
- ITCI Biotechnology: Pharmaceutical Preparations
- Sector
- EGP Real Estate
- ITCI Health Care
- Exchange
- EGP Nasdaq
- ITCI Nasdaq
- Market Cap
- EGP 8.9B
- ITCI 8.0B
- IPO Year
- EGP N/A
- ITCI N/A
- Fundamental
- Price
- EGP $183.46
- ITCI $74.72
- Analyst Decision
- EGP Buy
- ITCI Strong Buy
- Analyst Count
- EGP 14
- ITCI 11
- Target Price
- EGP $192.93
- ITCI $93.55
- AVG Volume (30 Days)
- EGP 273.6K
- ITCI 489.3K
- Earning Date
- EGP 10-22-2024
- ITCI 10-31-2024
- Dividend Yield
- EGP 3.08%
- ITCI N/A
- EPS Growth
- EGP 27.73
- ITCI N/A
- EPS
- EGP 4.79
- ITCI N/A
- Revenue
- EGP $608,993,000.00
- ITCI $564,526,000.00
- Revenue This Year
- EGP N/A
- ITCI $46.60
- Revenue Next Year
- EGP $9.93
- ITCI $37.06
- P/E Ratio
- EGP $38.83
- ITCI N/A
- Revenue Growth
- EGP 14.82
- ITCI 54.31
- 52 Week Low
- EGP $154.75
- ITCI $45.50
- 52 Week High
- EGP $192.61
- ITCI $84.89
- Technical
- Relative Strength Index (RSI)
- EGP 47.46
- ITCI 51.82
- Support Level
- EGP $183.63
- ITCI $71.75
- Resistance Level
- EGP $187.41
- ITCI $76.34
- Average True Range (ATR)
- EGP 2.84
- ITCI 1.65
- MACD
- EGP -0.29
- ITCI 0.09
- Stochastic Oscillator
- EGP 27.78
- ITCI 64.71
About EGP EastGroup Properties Inc.
EastGroup Properties Inc is an equity real estate investment trust. It is engaged in the development, acquisition, and operation of industrial properties in Sunbelt markets throughout the United States, predominantly in the states of Florida, Texas, Arizona, California, and North Carolina. The company manages a portfolio of industrial properties. The vast majority of these properties are multi-tenant business distribution buildings that provide large warehousing and office space for customers. The company derives its revenue in the form of rental income.
About ITCI Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.